Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand.
Hanif, M., Moon, S., Sullivan, M.P., Movassaghi, S., Kubanik, M., Goldstone, D.C., Sohnel, T., Jamieson, S.M., Hartinger, C.G.(2016) J Inorg Biochem 165: 100-107
- PubMed: 27470012 
- DOI: https://doi.org/10.1016/j.jinorgbio.2016.06.025
- Primary Citation of Related Structures:  
5KJ9 - PubMed Abstract: 
With the aim of increasing the accumulation of Ru anticancer agents in the tumor, a targeted delivery strategy based on a maleimide anchor for the biological vector human serum albumin (HSA) was developed. A group of piano stool Ru- and Os(η 6 -arene) complexes carrying a maleimide-functionalized N-phenyl-2-pyridinecarbothioamide (PCA) ligand was designed allowing for covalent conjugation to biological thiols. The complexes were characterized by NMR spectroscopy, ESI-MS, elemental analysis and single-crystal X-ray diffraction analysis. The compounds were shown to undergo halido/aqua ligand exchange reactions in aqueous solution, depending mainly on the metal center and the nature of the halide. In vitro cytotoxicity studies revealed low potency which is explained by the observed high reactivity of the maleimide to the thiol of l-cysteine (Cys), while the metal center itself shows little affinity to amino acids of the model protein lysozyme.
Organizational Affiliation: 
School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.